Elon Musk confirmed that Tesla Inc’s factory in Nevada was a target of an attempted cybersecurity attack, which he called serious, by a Russian national.
Musk made the confirmation via a tweet.
News website Teslarati said that Tesla was the unnamed company in a statement issued by the US Department of Justice about a planned attack.
The media reported that a Tesla employee helped the Federal Bureau of Investigation (FBI) thwart the attack.
The Justice Department identified the Russian national as 27-year-old Egor Igorevich Kriuchkov, who was arrested and charged with conspiracy to intentionally cause damage to a protected computer.
Kriuchkov attempted to recruit a Tesla employee to introduce malware into a system aimed at extracting data from the network, promising an incentive of $1 million upon doing so.
The Russian intends to use the data to force Tesla to pay a ransom.
Instead, the employee alerted the FBI, who thwarted the attack.


Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



